THE BLUE BOOK 2nd EDITION

First Page		Document Content
Date: 2011-09-02 06:22:11 Pharmaceuticals policy Health Pharmacy Clinical research Food and Drug Administration Marketing authorization Pharmacovigilance Certificate of pharmaceutical product Regulatory requirement Pharmaceutical sciences Pharmaceutical industry Pharmacology		THE BLUE BOOK 2nd EDITION Add to Reading List Source URL: whqlibdoc.who.int Download Document from Source Website File Size: 1,88 MB Share Document on Facebook

	TIGes vet Q&A-update - Sept 2013 DocID: 1rsZK - View Document
	BPGWorksharingEMA-CMDv DocID: 1rr9m - View Document
	CMDh meeting with representative of Interested Parties 19 May 2015  Type IA variation label implementation guidance. DocID: 1rqES - View Document
	Annex VI: Implementation of mandatory VNeeS format for Veterinary regulatory submissions <> "Error"Annex VI: Implementation of mandatory VNeeS format for Veterinary regulatory submissions \ MERGEFORMAT Annex VI: Imple DocID: 1rqtS - View Document
	Quasi Drug Rules in Japan December 2011 Quasi-drugs are a unique product classification in Japan. A quasi-drug is defined in Japan as products that have minimal to moderate pharmacologic activity but are restricted in us DocID: 1rpxR - View Document